Fwd: Eradicating Ebola: In U.S. Biomedical Research, We Trust

---------- Forwarded message ----------
From: National Institutes of Health (NIH) <nih.ocpl@service.govdelivery.com>
Date: Thu, Aug 28, 2014 at 8:34 AM
Subject: Eradicating Ebola: In U.S. Biomedical Research, We Trust
To: iammejtm@gmail.com

Having trouble viewing this email? View it as a Web page. You are receiving this message because you are subscribed to NIH Director's Blog for National Institutes of Health (NIH).     Eradicating Ebola: In U.S. Biomedical Research, We Trust 08/11/2014 10:05 AM EDT Updated August 28, 2014: Today, the National Institutes of Health (NIH) announced plans to begin initial human testing of an investigational vaccine to prevent Ebola virus disease. Testing of the vaccine, co-developed by NIH's National Institute of Allergy and Infectious Diseases (NIAID) and GlaxoSmithKline, will begin next week at the NIH Clinical Center in Bethesda, […]   Update Your E-mail Address | Add Subscriptions | Unsubscribe If you have questions or problems with the subscription service, please contact subscriberhelp.govdelivery.com. For all other inquiries about NIH programs and activities, please contact NIHinfo@od.nih.gov. Before writing, please view our Frequently Asked Questions page, our A-Z Health Topics page, or Search our website. This service is provided to you by the National Institutes of Health. NIH…Turning Discovery Into Health®  This email was sent to iammejtm@gmail.com using GovDelivery, on behalf of: National Institutes of Health (NIH) · 9000 Rockville Pike · Bethesda MD 20892 · 301-496-4000 / TTY 301-402-9612

--
Jeremy Tobias Matthews